Wednesday, November 4, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Comparative Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors on Sepsis in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study

International journal of chronic obstructive pulmonary disease · 2026 · Wu TJ, Chen CH, Wu HC et

By Maren Holt · Senior Reporter, GLP-1

Oct 29 20:00 ETSource: International journal of chronic obstructive pulmonary disease

From the source

Comparative Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors on Sepsis in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
International journal of chronic obstructive pulmonary disease · 2026 · Wu TJ, Chen CH, Wu HC et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42979119/

Prescribed peptides from $99/moSee all →